Gentium S.p.a. Receivables Turnover Ratio (GENT), from the fourth quarter 2013 to the fourth quarter 2012 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Gentium S.p.a.  (GENT)
 

Gentium S.p.a. Accounts Receivables Turnover Ratio from the fourth quarter 2013 to the fourth quarter 2012

Quarterly Results, Trends, Rankings, Statistics


Gentium S.p.a.'s ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2013 to a ratio of 9.65, above the company average. This is a clear sign of healthy business climate in the Biotechnology & Pharmaceuticals industry and improving liquidity at their respective customers, during the fourth quarter 2013. Average receivable collection period, for the Gentium S.p.a. in Dec 31 2013 quarter, has decreased to 38 days, compared to 54 days, in the 0 quarter.

If we take a look into Healthcare sector 278 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2013 from 0 to 3131.

What is Receivable Turnover Ratio?
What is Gentium S.p.a. Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GENT Receivables Turnover Ratio (Dec 31 2013)
IV. Quarter		 0
III. Quarter		 (Jun 30 2013)
II. Quarter		 0
I. Quarter		 (Dec 31 2012)
FY
Y / Y Receivable Change -1.95 % -15.68 % 20.2 % 19.66 % -
Y / Y Revenue Change 52.64 % - -69.24 % - -
Receivable Turnover Ratio (TTM) 9.65 6.8 8.01 11.73 13.65
GENT's Total Ranking # 3131 # 0 # 0 # 0 # 0
Accounts Receivable average collection period days 38 54 46 31 27
Seq. Receivable Change 0 % -21.97 % 28.15 % -1.95 % -14.01 %
Seq. Revenue Change - - - - 241.77 %


Receivable Turnover Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 30
Healthcare Sector # 279
Overall Market # 3131

Receivable Turnover Ratio Statistics
High Average Low
5.81 5.59 5.36
(Dec 31 2012)   (Dec 31 2013)





GENT Company Profile • Back to GENT Efficiency Comparisons • Compare GENT Receivables Turnover Ratio to its Competitors

Financial Statements
Gentium S.p.a.'s Accounts Receivable $ 7 Millions Visit GENT's Balance sheet
Gentium S.p.a.'s Sales TTM $ 67 Millions Visit GENT's Income Statement
Sources of GENT's Revenues Visit GENT's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
GENT's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
GENT's Growth Rates GENT's Roa GENT's Inventory Turnover Ratio GENT's Dividend Comparisons
GENT's Profitability Ratios GENT's Roi GENT's Asset Turnover Ratio GENT's Dividend Growth
GENT's Valuation Ratios GENT's Roe GENT's Financial Strength Ratios GENT's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2013, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2013 Receivable at quarter ending Dec 31 2013
Innoviva Inc   28.11 $ 4.561  Millions$ 0.162  Millions
Brookdale Senior Living Inc   26.95 $ 2,891.966  Millions$ 107.325  Millions
Noho, Inc.  25.70 $ 0.980  Millions$ 0.038  Millions
Achari Ventures Holdings Corp I  24.57 $ 143.699  Millions$ 5.848  Millions
Integrated Biopharma Inc  23.67 $ 50.563  Millions$ 2.136  Millions
Windtree Therapeutics Inc  23.16 $ 0.388  Millions$ 0.017  Millions
Adma Biologics Inc   21.90 $ 4.918  Millions$ 0.225  Millions
Acceleron Pharma inc  21.81 $ 57.230  Millions$ 2.624  Millions
Sunlink Health Systems Inc   20.84 $ 113.023  Millions$ 5.423  Millions
Immunogen inc   20.22 $ 76.110  Millions$ 3.763  Millions
Magellan Health inc   20.06 $ 3,546.317  Millions$ 176.797  Millions
Vanda Pharmaceuticals Inc   19.11 $ 33.879  Millions$ 1.773  Millions
Livewire Ergogenics Inc.  18.88 $ 0.146  Millions$ 0.008  Millions
Oragenics Inc   18.08 $ 1.032  Millions$ 0.057  Millions
Immunomedics Inc   17.37 $ 9.800  Millions$ 0.564  Millions
Assertio Holdings inc   16.90 $ 134.205  Millions$ 7.943  Millions
Galaxy Enterprises Inc   16.76 $ 4,936.382  Millions$ 294.570  Millions
International Stem Cell Corporation  15.95 $ 6.147  Millions$ 0.385  Millions
Invo Fertility Inc   15.71 $ 0.027  Millions$ 0.002  Millions
Cyteir Therapeutics Inc   15.35 $ 1,935.000  Millions$ 126.025  Millions
Tenet Healthcare Corp  15.19 $ 23,176.000  Millions$ 1,526.000  Millions
Chemed Corporation  15.06 $ 1,413.329  Millions$ 93.866  Millions
Ligand Pharmaceuticals Incorporated  15.01 $ 48.973  Millions$ 3.262  Millions
Fonar Corporation  14.11 $ 69.647  Millions$ 4.937  Millions
Curis Inc   14.08 $ 15.002  Millions$ 1.065  Millions
Correvio Pharma Corp   13.88 $ 4.511  Millions$ 0.325  Millions
Procyon Corporation  13.88 $ 2.969  Millions$ 0.214  Millions
Therapeutic Solutions International Inc   13.64 $ 0.312  Millions$ 0.023  Millions
Panbela Therapeutics Inc   13.61 $ 0.974  Millions$ 0.072  Millions
Ethema Health Corporation   13.37 $ 5.962  Millions$ 0.446  Millions

Date modified: 2026-09-10T02:29:34+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.